Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 73 to 78 of 78 entries
Sorted by: Best Match Show Resources per page
Empagliflozin Treatment Is Associated With Improvements in Cardiac Energetics and Function and Reductions in Myocardial Cellular Volume in Patients With Type 2 Diabetes.

Diabetes

Thirunavukarasu S, Jex N, Chowdhary A, Hassan IU, Straw S, Craven TP, Gorecka M, Broadbent D, Swoboda P, Witte KK, Cubbon RM, Xue H, Kellman P, Greenwood JP, Plein S, Levelt E.
PMID: 34610982
Diabetes. 2021 Dec;70(12):2810-2822. doi: 10.2337/db21-0270. Epub 2021 Oct 05.

Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of major adverse cardiovascular (CV) events and hospitalization for heart failure (HF) in patients with type 2 diabetes (T2D). Using CV MRI (CMR) and

A 30-Year-Old Man With Primary Cardiac Angiosarcoma.

JACC. Case reports

Jex N, Farley J, Thirunavukarasu S, Chowdhary A, Sengupta A, Greenwood J, Schlosshan D, Plein S, Levelt E.
PMID: 34317662
JACC Case Rep. 2021 May 12;3(6):944-949. doi: 10.1016/j.jaccas.2021.03.009. eCollection 2021 Jun.

A previously fit and well 30-year-old man presented with palpitations, fever, and pleuritic chest pain. Multimodality imaging and histopathology confirmed the diagnosis of primary cardiac angiosarcoma. We present the details of the presentation, diagnostic process using multimodality imaging, and...

A review of secondary interfacility trauma transfers meeting provincial prehospital trauma triage guidelines.

CJEM

Bischoff T, Briton J, Baumber B, Lewell M, Nolan B.
PMID: 34529242
CJEM. 2021 Nov;23(6):837-841. doi: 10.1007/s43678-021-00192-x. Epub 2021 Sep 16.

BACKGROUND: Severely injured patients benefit from early identification and trauma centre treatment. Ontario has provincial prehospital trauma triage guidelines identifying patients who require direct trauma centre transport. Trauma patients not identified as meeting this provincial trauma triage standard are...

Myocardial inflammation and energetics by cardiac MRI: a review of emerging techniques.

BMC medical imaging

Tsampasian V, Swift AJ, Assadi H, Chowdhary A, Swoboda P, Sammut E, Dastidar A, Cabrero JB, Del Val JR, Nair S, Nijveldt R, Ryding A, Sawh C, Bucciarelli-Ducci C, Levelt E, Vassiliou V, Garg P.
PMID: 34749671
BMC Med Imaging. 2021 Nov 08;21(1):164. doi: 10.1186/s12880-021-00695-0.

The role of inflammation in cardiovascular pathophysiology has gained a lot of research interest in recent years. Cardiovascular Magnetic Resonance has been a powerful tool in the non-invasive assessment of inflammation in several conditions. More recently, Ultrasmall superparamagnetic particles...

COVID-19 Clinical Phenotypes: Presentation and Temporal Progression of Disease in a Cohort of Hospitalized Adults in Georgia, United States.

Open forum infectious diseases

da Silva JF, Hernandez-Romieu AC, Browning SD, Bruce BB, Natarajan P, Morris SB, Gold JAW, Neblett Fanfair R, Rogers-Brown J, Rossow J, Szablewski CM, Oosmanally N, D'Angelo MT, Drenzek C, Murphy DJ, Hollberg J, Blum JM, Jansen R, Wright DW, Sewell W, Owens J, Lefkove B, Brown FW, Burton DC, Uyeki TM, Patel PR, Jackson BR, Wong KK.
PMID: 33537363
Open Forum Infect Dis. 2020 Dec 07;8(1):ofaa596. doi: 10.1093/ofid/ofaa596. eCollection 2021 Jan.

BACKGROUND: The epidemiological features and outcomes of hospitalized adults with coronavirus disease 2019 (COVID-19) have been described; however, the temporal progression and medical complications of disease among hospitalized patients require further study. Detailed descriptions of the natural history of...

Empagliflozin Treatment Is Associated With Improvements in Cardiac Energetics and Function and Reductions in Myocardial Cellular Volume in Patients With Type 2 Diabetes.

Diabetes

Thirunavukarasu S, Jex N, Chowdhary A, Hassan IU, Straw S, Craven TP, Gorecka M, Broadbent D, Swoboda P, Witte KK, Cubbon RM, Xue H, Kellman P, Greenwood JP, Plein S, Levelt E.
PMID: 34610982
Diabetes. 2021 Dec;70(12):2810-2822. doi: 10.2337/db21-0270. Epub 2021 Oct 05.

Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of major adverse cardiovascular (CV) events and hospitalization for heart failure (HF) in patients with type 2 diabetes (T2D). Using CV MRI (CMR) and

Showing 73 to 78 of 78 entries